Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.

Gaubert A, Kauss T, Marchivie M, Ba BB, Lembege M, Fawaz F, Boiron JM, Lafarge X, Lindegardh N, Fabre JL, White NJ, Olliaro PL, Millet P, Grislain L, Gaudin K.

Int J Pharm. 2014 Jul 1;468(1-2):55-63. doi: 10.1016/j.ijpharm.2014.04.023.

2.

Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Kauss T, Gaubert A, Boyer C, Ba BB, Manse M, Massip S, Léger JM, Fawaz F, Lembege M, Boiron JM, Lafarge X, Lindegardh N, White NJ, Olliaro P, Millet P, Gaudin K.

Int J Pharm. 2013 Jan 30;441(1-2):218-26. doi: 10.1016/j.ijpharm.2012.11.040.

3.

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, Fabre JL, Boiron JM, Lafarge X, White NJ, Olliaro PL, Millet P.

Int J Pharm. 2012 Oct 15;436(1-2):624-30. doi: 10.1016/j.ijpharm.2012.07.030.

4.

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership.

Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro PL, Millet P.

Malar J. 2011 May 23;10:142. doi: 10.1186/1475-2875-10-142.

5.

Allogeneic somatic cell therapy: process development challenges and future opportunities.

Fawaz FS, Hermiston TW, Dinter H.

Curr Opin Mol Ther. 2010 Aug;12(4):383-5. Review.

PMID:
20707031
6.

Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria.

Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P.

Int J Pharm. 2010 Jun 1. [Epub ahead of print]

PMID:
20685236
7.

Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria.

Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P.

Int J Pharm. 2010 Aug 16;395(1-2):198-204.

PMID:
20635516
8.

Investigation of porous graphitic carbon at high-temperature liquid chromatography with evaporative light scattering detection for the analysis of the drug combination artesunate--azithromycin for the treatment of severe malaria.

Gaudin K, Millet P, Fawaz F, Olliaro P, White NJ, Cassus-Coussère C, Agbahoungha U, Dubost JP.

J Chromatogr A. 2010 Jan 1;1217(1):75-81. doi: 10.1016/j.chroma.2009.11.015.

PMID:
19931089
9.

Determination of artesunate using reversed-phase HPLC at increased temperature and ELSD detection.

Gaudin K, Kauss T, Lagueny AM, Millet P, Fawaz F, Dubost JP.

J Sep Sci. 2009 Jan;32(2):231-7. doi: 10.1002/jssc.200800437.

PMID:
19101943
10.

Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis.

Kauss T, Moynet D, Rambert J, Al-Kharrat A, Brajot S, Thiolat D, Ennemany R, Fawaz F, Mossalayi MD.

Arthritis Res Ther. 2008;10(1):R19. doi: 10.1186/ar2372.

11.

In vitro release and stability of an artesunate rectal gel suitable for pediatric use.

Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AM, Dubost JP, Millet P, Fawaz F.

Int J Pharm. 2008 Apr 2;353(1-2):1-7.

PMID:
18082982
12.

Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpet.

Canal-Raffin M, L'azou B, Martinez B, Sellier E, Fawaz F, Robinson P, Ohayon-Courtès C, Baldi I, Cambar J, Molimard M, Moore N, Brochard P.

Part Fibre Toxicol. 2007 Sep 20;4:8.

13.

From ICU nurse to "miracle" patient.

Fawaz F.

RN. 2007 Aug;70(8):56. No abstract available.

PMID:
17760300
14.

Development of parallel line analysis criteria for recombinant adenovirus potency assay and definition of a unit of potency.

Ogawa Y, Fawaz F, Reyes C, Lai J, Pungor E Jr.

PDA J Pharm Sci Technol. 2007 May-Jun;61(3):183-93.

PMID:
17722485
15.

Stability of artesunate in pharmaceutical solvents.

Gaudin K, Langlois MH, Barbaud A, Boyer C, Millet P, Fawaz F, Dubost JP.

J Pharm Biomed Anal. 2007 Feb 19;43(3):1019-24.

PMID:
17084575
16.
17.

Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators.

Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD.

Biochem Pharmacol. 2006 Nov 15;72(10):1304-10.

PMID:
16959220
18.

A potency assay for a replication incompetent adenovirus type 5 carrying a human fgf-4 gene.

Fawaz FS, Elsheikh MA, Ogawa Y, Files JG, McCaman MT, Pungor E Jr.

Anal Biochem. 2005 Jul 1;342(1):34-44.

PMID:
15958178
19.

Comparative in vitro-in vivo study of two quinine rectal gel formulations.

Fawaz F, Koffi A, Guyot M, Millet P.

Int J Pharm. 2004 Aug 6;280(1-2):151-62.

PMID:
15265555
20.

Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.

Murakami P, Havenga M, Fawaz F, Vogels R, Marzio G, Pungor E, Files J, Do L, Goudsmit J, McCaman M.

J Virol. 2004 Jun;78(12):6200-8.

Items per page

Supplemental Content

Support Center